New eye drop aims to zap eyelash mites in common eye condition
NCT ID NCT07400965
First seen Feb 11, 2026 · Last updated May 22, 2026 · Updated 14 times
Summary
This study tests a new eye drop, GLK-321, for people with Demodex blepharitis, an eye condition caused by tiny mites that leads to eyelash dandruff and irritation. About 250 adults with signs of the condition will receive either the drug or a placebo for 6 weeks. The main goal is to see if the drops can clear the mite debris from eyelashes safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMODEX BLEPHARITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Glaukos Clinical Study Site
RECRUITINGNewport Beach, California, 92663, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.